MBOT, IMUX Stocks Make Big Moves

The few analysts covering MBOT and IMUX are very bullish

Sep 6, 2019 at 10:10 AM
facebook X logo linkedin

Healthcare stock Microbot Medical Inc (NASDAQ:MBOT) is gaining out of the gate today, possibly due to news the company will demonstrate its self-cleaning shunt at a conference next week. MBOT shares were last seen trading 10.2% higher at $5.40, though this still leaves them far below their brief January peak of $19.40. The stock has essentially trended lower since then, but short interest remains almost nonexistent, accounting for less than 1% of the total float.

And while there are only a couple of brokerage firms in coverage on the medical technology specialist, their average price target is $10. Perhaps next week's presentation could bring in more attention from Wall Street, good or bad.

Another healthcare stock making a strong move this morning is Immunic Inc (NASDAQ:IMUX). The shares are up 12.3% at $14.48, thanks to positive mid-stage trial data for the company's ulcerative colitis treatment. Today's move has the equity back above the 20-day moving average following a recent meet-up with the 50-day moving average. The $18 area should be on traders' radars, as it has marked a top in IMUX's three previous breakout attempts.

The security also only has two analysts in coverage, but they're extremely bullish, based on the average price target of $45. The shares traded as high as $46.80 back in April.



How to collect 1 dividend check every day for LIFE

Did you know you could collect 1 dividend check every day the market is open? You could also do it starting with just $605! For me, I'm collecting 70 dividend checks every quarter…which averages around 1.1 dividend checks every business day. There's no trading behind this... no penny stocks or high-risk investments. All you do is buy and hold and you're set. There's no set up required either. If you start buying the dividend stocks I show you today... you could collect 1 dividend per day starting as early as this week. Click here for all the details.